Göbel et al.42, did a study that provides evidence for the efficacy of ZA treatment in suppressing the activity of TGF-β, TNF-α, and IL-6 in ovarian cancer cells through the inhibition of the FPPS. This evidence concerns the gene TGFB1 and ovarian carcinoma.